Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
10.27 USD | -3.75% | -16.30% | -45.37% |
May. 23 | Transcript : Scholar Rock Holding Corporation Presents at UBS Obesity Therapeutics Day, May-23-2024 09:00 AM | |
May. 22 | Scholar Rock Starts Phase 2 Trial of Apitegromab in Obesity | MT |
- Stock Market
- Equities
- SRRK Stock
- News Scholar Rock Holding Corporation
- MarketScreener Strategies